Colby Bingham, MD
Dermatology · Burley, IDNPI 1164834073
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $782 of the $882 with a category attached, or 88.7%. 12 manufacturers reported payments, led by Lilly USA, LLC at 38.0% of the total. That places this record below the midpoint for dermatology clinicians in ID, where the typical reported total is $2,238.
Across 42 payments — averaging $20.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$335
- Johnson & Johnson$143
- Pfizer$108
- AbbVie$70
- Novartis$52
- Sun Pharmaceutical Industries Inc.$52
- plus $122 from 6 others
What the payments were for
- Food & beverage$78289%
- Education$10011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 16 | $335 |
| Johnson & Johnson | 3 | $143 |
| Pfizer | 6 | $108 |
| AbbVie | 5 | $70 |
| Novartis | 2 | $52 |
| Sun Pharmaceutical Industries Inc. | 3 | $52 |
| Boston Scientific | 2 | $33 |
| Sanofi | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| UCB, Inc. | 1 | $17 |
| Mimedx Group, Inc. | 1 | $16 |
| Galderma Laboratories, L.p. | 1 | $15 |
How this compares
$882 in reported general payments places this provider in the 30th percentile of 52 dermatology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 83 | $3,349 |
| Triamcinolone Acetonide | 105 | $1,005 |
| Fluorouracil | 13 | $835 |
| Fluocinonide | 16 | $824 |
| Tacrolimus | 11 | $540 |
| Ketoconazole | 50 | $515 |
| ValacyclovirValacyclovir Hcl | 37 | $513 |
| Hydroxychloroquine Sulfate | 26 | $461 |
| Fluconazole | 19 | $242 |
| Doxycycline Hyclate | 12 | $212 |
| Cephalexin | 37 | $203 |
| Mupirocin | 29 | $146 |
| Prednisone | 21 | $99 |
| Minoxidil | 19 | $81 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $74 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Burley
- Alan OlmsteadTwin Falls$405K
- Dustin PortelaBoise$164K
- Steven MingsBoise$82K
- Ryan HarrisMeridian$58K
- Jeffrey DraluckNorthbrook$36K
- Mark SchwendimanMeridian$9K
- Ryan OwsleyNampa$9K
- Kelsey FerrellMeridian$6K
- Nicholas BlickenstaffBoise$6K
- Randall BurrMeridian$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.